Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aurobindo Pharma Ltd.

Latest From Aurobindo Pharma Ltd.

People Round-Up: Bhadauria Named As Amneal CSO

Amneal gets a new CSO, Acino restructures its board under a new chair, the AAM adds an assistant general counsel and the British Biosimilars Association names a vice-chair, as well as other people movements from around the generics, biosimilars and value-added medicines industries.

Appointments Strategy

The Quality Lowdown: Foreign Burden, Border Destruction, Particles, Sterility

FDA asks about regulating foreign firms more and destroying drugs at the border, and questions firms about particles and aseptic practices.

Manufacturing Quality

Aurobindo In Trouble Again With FDA, Gets Form 483 With 11 Observations

The US Food and Drug Administration has flagged more problems at Aurobindo, issuing another Form 483 to the company over one of its plants in southern India. This one, containing 11 observations, sharply faults quality controls.

Manufacturing Regulation

Apotex Rumored To Be Weighing $3bn Sale

The family of murdered billionaire Barry Sherman who founded Canada’s largest generic drugmaker Apotex is rumored to be weighing whether to sell the business for as much as $3bn.

Strategy Canada
See All

Company Information